In the trial, people on the Wegovy pill lost about 13.6% of their body weight, while people on a placebo lost about 2% after 71 weeks
Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (4) reported the occurrence of at least one case of various thyroid disorders as adverse events
Buy Now Midi Custom Rx Midi Custom Rx offers a range of products for skin, hair, and sexual health, prescribed by your Midi clinician, and shipped directly to you from Midis own formulary
These effects collectively lead to weight loss